Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.
about
Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up.Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials.
P2860
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Reduced darunavir dose is as e ...... : a randomized clinical trial.
@en
type
label
Reduced darunavir dose is as e ...... : a randomized clinical trial.
@en
prefLabel
Reduced darunavir dose is as e ...... : a randomized clinical trial.
@en
P2093
P2860
P50
P356
P1476
Reduced darunavir dose is as e ...... : a randomized clinical trial.
@en
P2093
Cristina Miranda
DRV600 Study Group
Daniel Podzamczer
Elena Ferrer
José Moltó
José Ramón Santos
María Gracia Mateo
María Silvana Di Yacovo
Pere Domingo
P2860
P304
P356
10.1093/JAC/DKU516
P407
P577
2014-12-18T00:00:00Z